Nektar Therapeutics reported $-111355000 in EBITDA for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Agios Pharmaceuticals AGIO:US $ -98.67M 3.96M
ALKERMES ALKS:US $ -7.39M 30.91M
Amgen AMGN:US $ 3341M 185M
Astrazeneca AZN:US $ 4187M 687M
Baxter International BAX:US $ 911M 27M
Biocryst Pharmaceuticals BCRX:US $ -49.64M 2.37M
Biogen BIIB:US $ 674.7M 20.2M
Bristol Myers Squibb BMY:US $ 5772M 404M
Cara Therapeutics CARA:US $ -27848000 5.61M
Dr.Reddys Laboratories DRRD:IN IR 11929M 275M
Eisai 4523:JP Y -11598M 35133M
Eli Lilly And LLY:US $ 3005.6M 161.6M
Esperion Therapeutics ESPR:US $ -42836000 611K
Exelixis EXEL:US $ 87.73M 30.84M
Gilead Sciences GILD:US $ 3422M 1947M
GlaxoSmithKline GSK:LN 3120M 1062M
Halozyme Therapeutics HALO:US $ 76.45M 19.11M
Immunogen IMGN:US $ -22.38M 11.71M
IONIS PHARMACEUT IONS:US $ -53.21M 278.25M
Ironwood Pharmaceuticals IRWD:US $ 58.2M 1.25M
Karyopharm Therapeutics KPTI:US $ -34409000 81.51M
Macrogenics MGNX:US $ -63725000 8.44M
Merk MRK:US $ 6179M 492M
Mirati Therapeutics MRTX:US $ -183.59M 12.92M
Nektar Therapeutics NKTR:US $ -111.36M 1.88M
Neurocrine Biosciences NBIX:US $ 6.4M 60.6M
Novartis NOVN:VX SF 4552M 346M
Pfizer PFE:US $ 11182M 4046M
Sarepta Therapeutics SRPT:US $ -76.16M 19.51M
Seattle Genetics SGEN:US $ -115.96M 37.85M
Takeda 4502:JP Y 150655M 139878M
Teva Pharmaceutical TEVA:IT 1.11B 176M
Xencor XNCR:US $ 28.64M 65.11M
YTE INCY:US $ 144.1M 9.29M